ResMed, Inc.
http://www.resmed.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From ResMed, Inc.
ResMed Beats Q2 Revenue Estimates, Exits Portable Oxygen Business
ResMed beat Wall Street analysts’ projections for sales growth for the second quarter of 2021, announced exit of its portable oxygen market.
Top 100 Review: The Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19
2019 saw fewer revenues-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.
Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19
2019 saw fewer revenue-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.
Nyxoah Plans $70M+ IPO As It Starts IDE Trial For Neurostim Apnea Device
Belgian firm will float on Euronext Brussels; ResMed and Cochlear among existing investors who will invest in at least 25% of shares.
Company Information
- Industry
-
Medical Devices
- Diagnostic Equipment & Supplies
- Monitoring Equipment & Devices
-
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- Other Names / Subsidiaries
-
- CareTouch
- Curative Medical, Inc.
- HB Healthcare
- HEALTHCAREfirst
- Inova Labs, Inc.
- Jaysec Technologies LLC
- Laboratories Narval
- Maribo Medico
- MatrixCare
- Mediserv
- Propeller Health
- SleepScore Labs, Umbian
- Unimedis
- Brightree LLC.